These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats.
    Author: Fujita T, Sato Y.
    Journal: Kidney Int; 1983 Dec; 24(6):731-9. PubMed ID: 6325798.
    Abstract:
    The role of a natriuresis in the protective effect of potassium against the development and maintenance of salt-induced hypertension was studied. Uninephrectomized rats showed average systolic pressures of 177 +/- 3 mm Hg after the 28 days of treatment with DOCA while receiving a 1% NaCl solution to drink. The supplements of 0.2 and 1% KCl solution could counteract the blood-pressure raising effect of NaCl in a dose-related fashion: The average pressures on day 28 at these dosages were 131 +/- 3 and 120 +/- 3 mm Hg, respectively. The cumulative sodium retention was significantly less in the KCl-supplemented rats than the DOCA-salt rats. Exchangeable body sodium (sodium "space") at weeks 1 and 4 was significantly increased in the DOCA-salt rats as compared to those in the vehicle-treated rats. But, the potassium supplement could reduce sodium "space" dose-relatedly in the DOCA-salt rats. Overall, there was a close correlation between the systolic pressures and sodium "space" at week 4 (r = 0.811, P less than 0.01). The results suggest that potassium may attenuate the rise in blood pressure during the DOCA-salt treatment in uninephrectomized rats, mainly as a result of inhibition of sodium retention, by increasing renal sodium excretion.
    [Abstract] [Full Text] [Related] [New Search]